Repligen entered into a five-year supply agreement with GE Healthcare for recombinant Protein A, a consumable used in the manufacture of mAbs. This agreement provides for Repligen to continue to be a strategic supplier to GE Healthcare through 2014.


GE Healthcare sells chromatography products that incorporate Repligen’s recombinant Protein A to the biopharmaceutical industry for the manufacture of mAbs.

Previous articleLabAuto 2010
Next articleCorning and Sartorius Stedim Biotech to Provide Combined Cell-Culture Product Catalog